Align Tech (ALGN) Earnings Dates, Call Summary & Reports

3,369 Followers

Earnings Data

Report Date

Jul 29, 2026

After Close (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

2.64

Last Year’s EPS

2.49

Same Quarter Last Year

Analyst Consensus

Moderate Buy

Based on 14 Analysts Ratings

Earnings Call Summary

Q1 2026

Earnings Call Date:Apr 29, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call communicated strong operational and financial performance: record Clear Aligner volumes, broad international growth, margin expansion, EPS and cash generation, and traction for commercial and product initiatives (DSP, financing, iTero/exocad integration). Management reiterated full-year guidance while taking a prudent stance given geopolitical uncertainty and flagged near-term risks (North America softness, Systems & Services seasonality, higher OpEx and resin/freight exposure). On balance the positives — robust volume growth, improving margins, product/platform momentum and capital returns — outweigh the challenges, though the company remains cautious on macro risks.

Company Guidance

Align guided Q2 2026 revenue of $1.040–$1.060 billion (≈+3%–5% YoY), with Clear Aligner volumes expected to be up sequentially and year‑over‑year, Clear Aligner ASPs flat sequentially and YoY, and Systems & Services revenue up sequentially, while assuming some Q2 impact from the Middle East. For fiscal 2026 they reaffirmed full‑year revenue growth of +3%–4% YoY, Clear Aligner volume growth of mid‑single digits, an expected full‑year ASP decline of ~1%–2% YoY, GAAP operating‑margin targets cited as ~16.4% in one comment and a full‑year objective slightly below 18% (≈+400 bps vs. 2025), non‑GAAP operating‑margin references of ~21.5% and a reaffirmed full‑year target of ~23.7% (+100 bps YoY), an FX benefit trending toward ~100 basis points for the year, capital expenditures of $125–$150 million, and a planned additional share repurchase of up to $200 million over six months beginning May 1.

Topline Growth

Total Q1 revenue of $1.041 billion, up 6.2% year-over-year (constant currency benefit ~4.5% / $44.9M), driven primarily by Clear Aligner demand.

Record Clear Aligner Volume and ASP Expansion

Clear Aligner shipments reached a record 686,000 cases, up 6.7% year-over-year (1.3% sequentially). Clear Aligner revenue was $856M, up 7.4% YoY. Average selling price per case was $1,250, up 1% ($10) YoY.

Broad-Based Patient and Channel Growth

Adults treated totaled 449,000 (up 7.8% YoY); teens & kids started 237,000 (up 4.8% YoY). Shipments grew double-digits in EMEA, APAC and Latin America; dentist/orthodontist channels both expanded (orthodontist shipments +7.4% YoY; GP shipments +5.6% YoY). DSO volumes grew double-digits and comprised ~25% of global volumes.

Margin and Profitability Improvement

GAAP gross margin improved to 70.8% (+1.4 pts YoY); Clear Aligner gross margin 71.6% (+1.1 pts YoY). GAAP operating margin was 13.6% (+0.3 pts YoY); non-GAAP operating margin expanded to 21.5% (+2.5 pts YoY). Non-GAAP EPS was $2.58, up 21% YoY.

Cash Generation, Deleveraging and Capital Returns

Cash & cash equivalents of $1,059.8M (up $186.8M YoY). Q1 operating cash flow $151M and free cash flow $120.3M. Completed $200M buyback and announced up to an additional $200M repurchase over 6 months; $800M remains available under authorization.

Systems & Platform Adoption Milestones

Installed base of active iTero scanners exceeded 125,000 globally and >12M iTero scans performed in the quarter. Exocad delivered double-digit revenue growth; Invisalign ART pilot launched in U.S.; iTero Lumina adoption and service/CPO sales contributed to Systems & Services revenue of $184.1M.

Commercial Initiatives Gaining Traction

Doctor Subscription Program (DSP) and DSP touch-up cases grew double-digits YoY across regions. Patient financing (HFD) live in over 4,000 U.S. offices and Invisalign Pay now used in a majority of Invisalign cases in Brazil—both supporting affordability, conversion and adoption.

Operational Improvements and Revenue Recognition Benefits

Clear Aligner deferred revenue decreased $77.2M (6.4% YoY) reflecting rollout of configurations with fewer/no future obligations (improves revenue recognition timing and cash conversion). Company cited lower refinement rates, improved treatment predictability and manufacturing throughput as ongoing margin drivers.

Align Tech (ALGN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ALGN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jul 29, 2026	2026 (Q2)	2.64 / -	2.49	―	―	―
Apr 29, 2026	2026 (Q1)	2.29 / 2.58	2.13	21.13% (+0.45)
Feb 04, 2026	2025 (Q4)	2.97 / 3.29	2.44	34.84% (+0.85)
Oct 29, 2025	2025 (Q3)	2.40 / 2.61	2.35	11.06% (+0.26)
Jul 30, 2025	2025 (Q2)	2.57 / 2.49	2.41	3.32% (+0.08)
Apr 30, 2025	2025 (Q1)	1.99 / 2.13	2.14	-0.47% (-0.01)
Feb 05, 2025	2024 (Q4)	2.45 / 2.44	2.42	0.83% (+0.02)
Oct 23, 2024	2024 (Q3)	2.31 / 2.35	2.14	9.81% (+0.21)
Jul 24, 2024	2024 (Q2)	2.34 / 2.41	2.22	8.56% (+0.19)
Apr 24, 2024	2024 (Q1)	1.97 / 2.14	1.82	17.58% (+0.32)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ALGN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Apr 29, 2026	$178.40	$176.01	-1.34%
Feb 04, 2026	$161.30	$175.62	+8.88%
Oct 29, 2025	$131.91	$138.43	+4.94%
Jul 30, 2025	$203.57	$129.01	-36.63%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.